Summary. In order to investigate whether the ability of peripheral blood monocytes to bind bacteria is impaired in diabetes, we studied carbohydrate-binding ("lectin-like") receptors and the receptor for the Fc portion of immunoglobulin on monocytes from 25 male Type 1 (insulin-dependent) diabetic patients and 10 age-matched healthy control subjects. Peripheral blood monocytes from the diabetic patients expressed lower levels of "lectin-like" receptors compared to the control subjects, whereas the expression of the receptor for the Fc portion of immunoglobulin was similar in both populations. There was no correlation between the degree of "lectin-like" binding activity and plasma glucose concentration or glycaemic control. Recognition of unopsonized bacteria by the "lectin-like" receptor is impaired in Type I diabetes; this may affect the efficient elimination of potential pathogens.
The mechanisms responsible for the immune dysfunction and increased susceptibility to infection [1, 2] seen in patients with diabetes mellitus are not yet understood. Studies with alloxan-induced diabetes in mice suggest that macrophage cell-surface receptors and function are altered in the diabetic state [3] . These cells perform critical and diverse functions in the induction, regulation and amplification of the immune response [4] . Their activity is controlled by recognition events at the cell surface. Identified receptor sites on macrophage cell membranes include receptors for the Fc portion of immunoglobulin (Fc), complement components, carbohydrates and various lymphokines. The alteration in the expression of these cell surface molecules may drastically affect cellular activity and function.
A carbohydrate binding receptor that recognises various bacterial species by their cell wall sugars has been described [5] . This "lectin-like" receptor is blocked by simple sugars such as D-glucose and D-galactose [6] , and is associated with the major histocompatibility antigens that are involved in the inductive phase of the immune response [7] .
In this study we report on the expression of "lectinlike" and Fc receptors on monocytes from Type i diabetic patients, and relate this to the level of plasma glucose, fructosamine and glycosylated haemoglobin.
Materials and methods

Preparations of monocyte monolayers
Peripheral blood was obtained from 25 male Type 1 diabetic patients, age 30.2_ 1.0 years (mean + SEM), mean duration of diabetes 10.8+1.5 years, and from 10 non-diabetic male volunteers, age 27.6 + 1.5 years. The diabetic patients received no medication other than insulin, and had no other underlying illnesses, particularly infections. Mononuclear cells were purified on Ficoll/Hypaque (density 1.077 g/ml) by the method of Boyum [8] , and were resuspended in Eagle's minimum essential medium without serum to give a final concentration of 2 • 105 monocytes/ml. One millilitre of the cell suspension was layered onto 13 mm diameter (no. 1) glass coverslips in tissue culture plate wells and incubated at 37 ~ for 1 h. Non-adherent cells were removed by washing with Dulbecco's phosphate buffered saline (D.PBS).
Detection of "lectin-like" receptors
Staphylococcus epidermidis obtained from the departmental teaching collection was grown in nutrient broth (Oxide no. 2, Oxide Ltd, Basingstoke, Hampshire, UK), harvested in log phase and killed by 24 h exposure to 0.5% formalin at 4~ The organisms were washed with 0.15 mol/1 NaC1 to remove the formalin and stored at 4~ for no longer than 3 weeks.
The monocyte monolayers were overlaid with t ml of the bacteria in D.PBS containing Ca ++ and Mg ++ ions (0.9 mmol/1 and 0.4 mmol/1 respectively) and incubated for 1 h at 37~ Non-attached organisms were removed by repeated washing with D.PBS. Coverslips were air dried, fixed in methanol and stained with May Grunwald/Giemsa. "Lectin-like" receptor expression was estimated .., ti Z~ 12-9 9
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Detection of Fc receptors
Sheep erythrocytes coated with immunoglobulin (EAo) were prepared by incubating equal volumes of mouse monoclonal anti-sheep erythrocytes antibody (IgG2b MAS 13c Sera-Lab Ltd., Crawley Down, Sussex, UK) diluted in Hanks' balanced salt solution (BSS) and sheep erythrocytes (109/ml) for 30 min at 37 ~ The sensitized sheep erythrocytes were washed twice with Hanks' BSS and stored at 4 ~ for no longer than 1 week. Two millilitres of EAr (2.5 x 107/ml) were added to each monolayer, centrifuged for 8 rain at 50 g and incubated for 45 min at 20~ Non-adherent erythrocytes were removed by gentle washing with Hanks' BSS. The coverslips were then treated and counted as for "lectin-like" receptors.
Measurement of plasma glucose, glycosylated haemoglobin and fructosamine
Plasma glucose was measured using a standard glucose oxidase method. Total glycosylated haemoglobin was determined by an electrophoretic method [9] and serum fructosamine was measured by the method of Johnson et al. [10] adapted for use on the Cobas Fara cen-trifugal analyser (Roche Products Ltd., Welwyn Garden City, UK). Values for the normal control subjects were: glycosylated haemoglobin 5.7-8.2%, fructosamine 1.1-1.6 mmol/1 and plasma glucose 3.2-5.3 mmol/1.
Statistical analysis
The levels of "lectin-like" and Fc receptors on the monocytes from the Type I diabetic patients and control subjects were compared using Student's t-test, and correlations were analysed using linear leastsquares fit. A p value of < 0.05 was considered statistically significant.
Results
The percentage of monocytes from Type I diabetic patients and normal controls that bound unopsonised Staphylococcus epidermidis is shown in Figure 1 . The level of detectable "lectin-like" receptors was significantly lower in the Type I diabetic patients at all doses of the bacterium (p< 0.001). In contrast, there was no difference in Fc receptor expression between the two groups (Fig. 2) . There was no difference between the percentage of monocytes in the ficoll/hypaque interface from the diabetic patients and the control subjects.
The percentage of "lectin-like" receptor positive monocytes, at the highest bacterial concentration used (3 x 109/ml), did not correlate with the levels of plasma glucose, total glycosylated haemoglobin and serum fructosamine (Fig. 3) .
Discussion
The monocyte "lectin-like" receptor that recognises, binds and phagocytoses unopsonised bacteria may be important in the initiation of an immune response in a non-immune individual. This receptor is blocked in vitro by concentrations of D-glucose similar to those found in the plasma of hyperglycaemic patients [6] . Studies with alloxan-induced diabetic mice suggest that the diabetic environment affects the function of mononuclear phagocytes [3] . In the mouse model the binding activity of the "lectin-like" receptor is depressed; in addition, macrophages from diabetic mice are less efficient as accessory cells in antigen-dependent T cell proliferation than normal macrophages. Thus, "lectin-like" receptor expression and activity can be modulated by exposure to elevated glucose concentrations.
The results of this study demonstrate that monocytes from insulin-dependent diabetic patients have a lower level of detectable "lectin-like" receptors than monocytes from normal non-diabetic individuals. The mechanisms for this depressed expression of the carbohydrate recognising receptor is not clear. There appears to be a specific effect on the "lectin-like" receptor, since there was no difference in Fc receptor expression between diabetic patients and normal control subjects (Fig. 2) . The fact that greater than 70% of peripheral blood monocytes express detectable Fc receptors, whereas only about 20% bind Staphylococcus epidermidis, is consistent with the marked heterogeneity found in mononuclear phagocyte populations [11] . It seems unlikely that the lower levels of "lectin-like" receptor were the result of direct blocking of the receptors by the elevated blood glucose levels. The monocytes were exposed to prolonged incubations and washings in medium with physiological levels of glucose (5 mmol/1). The receptor on monocytes from both diabetic patients and control subjects can be inhibited to the same extent in vitro by glucose at a concentration of 20 mmol/1 (J.Stewart, unpublished observation), suggesting that the binding seen in the diabetes was still mediated by the "lectin-like" receptor. In addition, there was no correlation between the plasma glucose level at the time of venepuncture and the level of "lectin-like" receptor expression (Fig. 3) .
There was no evidence that the degree of prevailing glycaemic control over the previous few weeks, as assessed by total glycosylated haemoglobin and fructosamine, had any additional effect on the expression of "lectin-like" receptors (Fig. 3) . The binding assay used in this study cannot distinguish between the possibility that the reduced binding in diabetes is due to a decrease in receptor number and/or affinity, or to a reduction in the proportion of monocytes expressing the receptor. Assays are being developed to investigate this point. It is possible that once the monocytes have been exposed to a hyperglycaemic environment their "lectin-like" receptor activity is impaired to its maximal extent. Prolonged exposure to high concentrations of glucose could modulate the activity or expression of the "lectin-like" receptor. As has been proposed for other membrane components [12] , high blood glucose concentration may lead to non-enzymatic glycosylation of the receptor, altering its activity. Alternatively, continuous interactions of glycosylated serum proteins with the receptor may disturb its normal cellular distribution and turnover. Although one patient had a total glycosylated haemoglobin level within the normal range, he still had lower bacterial binding levels than the control subjects.
Thus, insulin-dependent diabetic patients have lower levels of "lectin-like" receptors on their monocytes, and this may have consequences for their ability to mount as effective an immune response as non-diabetic persons. Even a brief delay in raising a specific defence, through the activities of macrophages, may be critical when challenge occurs. This may partially explain the increased susceptibility to infection characteristic of diabetic patients.
